Beyond Air (XAIR) Free Cash Flow Growth (1y) (2017 - 2026)
Powered by 
Analysis
Beyond Air (XAIR) Free Cash Flow Growth (1y) (2017 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 180.55 Bn | 174.95 Bn | 7.27 Bn | 28.87% |
| 2 | Intuitive Surgical | 127.52 Bn | 122.30 Bn | 1.96 Bn | 69.33% |
| 3 | Medtronic | 117.07 Bn | 108.26 Bn | 6.34 Bn | 120.89% |
| 4 | Stryker | 103.72 Bn | 100.25 Bn | 4.50 Bn | 14.12% |
| 5 | Boston Scientific | 63.40 Bn | 62.86 Bn | 3.85 Bn | 13.29% |
| 6 | Edwards Lifesciences | 49.71 Bn | 45.45 Bn | 1.35 Bn | 142.84% |
| 7 | Alcon | 33.00 Bn | 31.55 Bn | 1.68 Bn | -0.16% |
| 8 | Dexcom | 32.13 Bn | 30.18 Bn | 830.00 Mn | -11.68% |
| 9 | Steris | 20.71 Bn | 20.23 Bn | 684.20 Mn | -14.34% |
| 10 | Beyond Air | 2.25 Mn | -8.67 Mn | 225,000.00 | -12.34% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.34% |
| Mar 31, 2026 | 35.06% |
| Dec 31, 2025 | 48.57% |
| Sep 30, 2025 | 67.65% |
| Jun 30, 2025 | 63.25% |
| Mar 31, 2025 | 33.19% |
| Dec 31, 2024 | 45.43% |
| Sep 30, 2024 | 9.23% |
| Jun 30, 2024 | 28.39% |
| Mar 31, 2024 | -20.97% |
| Dec 31, 2023 | -65.74% |
| Sep 30, 2023 | -97.89% |
| Jun 30, 2023 | -152.86% |
| Mar 31, 2023 | -26.94% |
| Dec 31, 2022 | -255.47% |
| Sep 30, 2022 | -283.44% |
| Jun 30, 2022 | -79.92% |
| Mar 31, 2022 | -47.47% |
| Dec 31, 2021 | 208.85% |
| Sep 30, 2021 | 215.76% |